propranolol has been researched along with opc 3911 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belfrage, P; Degerman, E; Ekholm, D; Eriksson, H; Manganiello, VC; Ridderstråle, M; Smith, CJ; Tornqvist, H | 1 |
1 other study(ies) available for propranolol and opc 3911
| Article | Year |
|---|---|
Evidence for the key role of the adipocyte cGMP-inhibited cAMP phosphodiesterase in the antilipolytic action of insulin.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adipocytes; Animals; Cyclic GMP; Insulin; Lipolysis; Male; Phosphodiesterase Inhibitors; Propranolol; Quinolones; Rats; Rats, Sprague-Dawley; Sterol Esterase | 1995 |